The prospect of deep Medicaid cuts has become a flashpoint in Congress, with leaders of both parties accusing their counterparts of lying. Get to know each of these companies by learning about their ...

The prospect of deep Medicaid cuts has become a flashpoint in Congress, with leaders of both parties accusing their counterparts of lying.

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts said.

Collective headcount across the “big six” holding companies fell by 1.6% in 2024, the first drop since the pandemic hit in 2020, according to a Campaign analysis. The drop marks an end to collective ...

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

The Justice Department dropped a challenge, filed under President Joe Biden, to Idaho’s strict abortion ban. St. Luke’s Health System is continuing with its own lawsuit.

Kennedy and others in Trump’s orbit have found a particularly warm reception among some of the biggest supplement evangelists: influencers, who often promote personal responsibility, in the form of ...

The White House pulled the nomination of former Rep. Dave Weldon, (R-FL), to head the Centers of Disease Control and Prevention on Thursday morning, just hours before he was set to appear before the ...

Joele Fank cofounder and managing partner Joele Frank and partners Aaron Palash, Jamie Moser and Adam Pollack are handling Walgreens while partners Michael Freitag and Arielle Rothstein are advising ...

Novartis shareholders elected Giovanni Caforio as new member and Chair of the Board of Directors as well as Elizabeth McNally as new member of the Board of Directors. Joerg Reinhardt, Charles L.

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...